-
公开(公告)号:US20240316123A1
公开(公告)日:2024-09-26
申请号:US18616811
申请日:2024-03-26
申请人: ZBiotics Company
发明人: Zachary Abbott
IPC分类号: A61K35/742 , A61K9/00 , A61K35/00 , A61K35/741 , A61K38/00 , A61P39/02 , C07K14/32 , C12N9/02 , C12N15/63
CPC分类号: A61K35/742 , A61K9/0053 , A61P39/02 , C07K14/32 , C12N9/0008 , C12N15/63 , C12Y102/01003 , A61K9/0095 , A61K2035/115 , A61K35/741 , A61K38/00
摘要: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
-
公开(公告)号:US11975033B2
公开(公告)日:2024-05-07
申请号:US17080185
申请日:2020-10-26
申请人: ZBiotics Company
发明人: Zachary Abbott
IPC分类号: A61K35/742 , A61K9/00 , A61P39/02 , C07K14/32 , C12N9/02 , C12N15/63 , A61K35/00 , A61K35/741 , A61K38/00
CPC分类号: A61K35/742 , A61K9/0053 , A61P39/02 , C07K14/32 , C12N9/0008 , C12N15/63 , C12Y102/01003 , A61K9/0095 , A61K2035/115 , A61K35/741 , A61K38/00
摘要: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
-
公开(公告)号:US11696932B2
公开(公告)日:2023-07-11
申请号:US16646989
申请日:2018-09-13
申请人: ZBiotics Company
发明人: Zachary Abbott
IPC分类号: A61K35/742 , C12N15/63 , A61K35/741 , A61P39/02 , C12N9/02 , A61K9/00 , C07K14/32 , A61K35/00 , A61K38/00
CPC分类号: A61K35/742 , A61K9/0053 , A61P39/02 , C07K14/32 , C12N9/0008 , C12N15/63 , C12Y102/01003 , A61K9/0095 , A61K35/741 , A61K38/00 , A61K2035/115
摘要: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
-
公开(公告)号:US20210121506A1
公开(公告)日:2021-04-29
申请号:US17080185
申请日:2020-10-26
申请人: ZBiotics Company
发明人: Zachary Abbott
摘要: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
-
公开(公告)号:US10849938B2
公开(公告)日:2020-12-01
申请号:US16048147
申请日:2018-07-27
申请人: ZBiotics Company
发明人: Zachary Abbott
IPC分类号: A61K35/741 , A61P39/02 , A61K35/742 , C12N9/02 , A61K9/00 , C12N15/63 , C07K14/32 , A61K35/00 , A61K38/00
摘要: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
-
-
-
-